JW Therapeutics News and Activities

JW Therapeutics is a company listed under the stock ticker 2126 (HK).

View the org chart displaying its 22 main executives

Most searched biographies at JW Therapeutics

• Tian Feng, Chief Executive Officer and Executive Director
• Min Liu, Chairman of the Board
• Peng Kuan Chang, Independent Non-Executive Director

Popular executive movements at JW Therapeutics

• Tian Feng will join the company as Chief Executive Officer and Executive Director on Dec. 29, 2025  (posted on December 18 2025).

Create your alert
to follow the executive moves at JW Therapeutics.

JW Therapeutics has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by JW Therapeutics

Social media about JW Therapeutics

• JW Therapeutics on Wikipedia, Google News & Yahoo Finance
• JW Therapeutics on LinkedIn, X (Twitter) & YouTube